Open to patients and clinicians
Date: Wednesday, July 12
Time : 6:30 pm – 8:30 pm
Place: Lovett Inn ( http://www.lovettinn.com/main.php )
Speakers: Dr Shannon Schrader and Nelson Vergel
1- Updated review of HIV pipeline products
2- How to best maximize the effects of Prezista, the newly approved protease inhibitor for multi-protease resistant virus
3- What is virtual monotherapy and what are its risks?
4- What are the best predictors of treatment response in patients with multidrug resistant virus?
5- Information on Fuzeon’s needle free injection device (BOSS Study)
6- Integrase Inhibitors- Why the hype?
7- Are oral entry inhibitors safe and effective? What do the studies so far show?
8- Gene therapy in HIV- An update
9- Questions and Answers
Reply to this email or email@example.com to reserve a seat since space is very limited.
For those who cannot attend, there will be a live chat at thebody.com on July 10th at 2:30 pm Central. Questions can be sent in now. A full transcript will be available after the chat. For more information: